P527: PHASE 1 TRIAL OF PEGCRISANTASPASE IN COMBINATION WITH VENETOCLAX IN ADULTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML) - SAFETY, EFFICACY AND PK/PD IN THE FIRST TWO COHORTS

• Y. Liu,
• O. M. Bah,
• D. Bollino,
• K. Caprinolo,
• J. Zarrabi,
• S. Philip,
• R. G. Lapidus,
• E. T. Strovel,
• Z. N. Singh,
• M. E. Kallen,
• Y. Ning,
• R. Koka,
• S. Niyongere,
• V. H. Duong,
• M. R. Baer,
• M. Graveno,
• A. Emadi

Affiliations

Y. Liu

1 University of Maryland Greenebaum Comprehensive Cancer Center

O. M. Bah

1 University of Maryland Greenebaum Comprehensive Cancer Center

D. Bollino

1 University of Maryland Greenebaum Comprehensive Cancer Center

K. Caprinolo

1 University of Maryland Greenebaum Comprehensive Cancer Center

J. Zarrabi

1 University of Maryland Greenebaum Comprehensive Cancer Center

S. Philip

1 University of Maryland Greenebaum Comprehensive Cancer Center

R. G. Lapidus

1 University of Maryland Greenebaum Comprehensive Cancer Center

E. T. Strovel

2 Pediatrics

Z. N. Singh

3 Pathology, University of Maryland School of Medicine, Baltimore, United States of America

M. E. Kallen

3 Pathology, University of Maryland School of Medicine, Baltimore, United States of America

Y. Ning

3 Pathology, University of Maryland School of Medicine, Baltimore, United States of America

R. Koka

3 Pathology, University of Maryland School of Medicine, Baltimore, United States of America

S. Niyongere

1 University of Maryland Greenebaum Comprehensive Cancer Center

V. H. Duong

1 University of Maryland Greenebaum Comprehensive Cancer Center

M. R. Baer

1 University of Maryland Greenebaum Comprehensive Cancer Center

M. Graveno

1 University of Maryland Greenebaum Comprehensive Cancer Center

A. Emadi

1 University of Maryland Greenebaum Comprehensive Cancer Center